<DOC>
	<DOCNO>NCT00510263</DOCNO>
	<brief_summary>The main objective study study effect prednisolone valaciclovir , equal importance , compare placebo treatment Bell´s palsy . The combination prednisolone valaciclovir also study .</brief_summary>
	<brief_title>Scandinavian Bell 's Palsy Study</brief_title>
	<detailed_description>Study Design : This multicentre randomise double-blind placebo-controlled study . Study medication : Prednisolone 60 mg per day 5 day , taper 10 mg per day total treatment time 10 day . Valaciclovir 1000 mg 3 time per day 7 day . Prednisolone valaciclovir use combination separately . One patient four receive placebo . Study Duration : Study medication take 10 day . The subject follow 12 month initiation treatment . Follow-up visit 11-15 day start therapy 1 , 2 , 3 , 6 12 month onset palsy . Study Setting : The study conduct 17 ENT-clinics Sweden Finland , monitor member board Scandinavian Bells Palsy Study ( SBPS ) Study Subjects : Otherwise healthy subject unilateral acute idiopathic facial palsy . A total 800 subject include study . Study Treatments : The subject randomise one follow treatment arm oral administration study drug : 1 . Prednisolone + placebo 2 . Valaciclovir + placebo 3 . Prednisolone + valaciclovir 4 . Placebo + placebo Treatment initiate within 72 hour onset palsy continued 10 day . Measurements : The first follow-up clinical examination schedule within 3 day complete treatment . Further follow-up visit schedule 1 , 2 , 3 6 month onset palsy . If complete recovery occur 2 month visit , 3 6 month visit necessary . If complete recovery present 3 month 6 month visit exclude . A final follow-up exam always perform 12 month . The clinical examination include routine examination ear , nose throat , grade palsy accord Sunnybrook House Brackmann grade scale registration symptom pain , eye irritation , dysacusis impair taste . Blood test Lyme Borreliosis drawn acute ( first ) visit follow-up visit 2 month . Primary Endpoint : The primary endpoint time complete clinical recovery ( defined 100 Sunnybrook facial nerve grade scale ) Bell 's palsy . The subject categorise heal healed month 1 , 2 , 3 , 6 12 month . Treatments compare use Generalized Wilcoxon rank sum test . Patients data miss healing time include censor last visit patient heal . Secondary endpoint : The secondary endpoint study comparison different treatment arm regard : - Proportion patient complete heal palsy compare incomplete heal at12 month onset . - Influence outcome 12 month time hour onset palsy begin study medication . - Proportion patient develop severe palsy first week onset . - The total duration pain , around ipsilateral ear ipsilateral side face , onset palsy . - The proportion subject severe pain ( VAS 3 ) different treatment arm . - Occurrence synkinesia different treatment arm time . - Occurrence facial spasm contracture different treatment arm time . - Severity remain facial symptom patient heal 12 month prescheduled study visit record Sunnybrook Facial Grading System . Safety Evaluations : Adverse event assess first study month . Adverse event report patient 's file patient CRF study .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Bell Palsy</mesh_term>
	<mesh_term>Facial Paralysis</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1 . Be good general health 18 75 year age . 2 . Have acute peripheral unilateral idiopathic facial palsy . 3 . Not 72 hour must pass onset palsy initiate study medication . 4 . The subject must provide freely give write informed consent . 1 . Subjects use antiherpetic medication , except locally apply formulation , within last 2 week . 2 . Subjects ongoing systemic steroid medication another disease . 3 . Pregnant woman nurse mother . 4 . Subjects diabetes . 5 . Subjects presently suffer gastric duodenal ulcer . If history previous peptic ulcer dyspepsia prophylactic medication must prescribe take study . 6 . Subjects history tuberculosis . 7 . Subjects psychiatric diagnosis risk influence study drug might affect patient´s ability complete study . 8 . Subjects hypertension well control . 9 . Subjects present , history , serious heart disease . 10 . Subjects history glaucoma . 11 . Subjects history hepatic disease . 12 . Subjects neurological disease . 13 . Subjects history renal disease know creatinine clearance &lt; 30mL/min . 14 . Subjects acute otitis history ipsilateral chronic otitis . 15 . Subjects history recent head injury . 16 . Fertile , sexually active woman employ acceptable method contraception and/or woman plan become pregnant period intake study medication . 17 . Subjects history immunodeficiency syndrome . 18 . Subjects allergy sensitivity aciclovir valaciclovir , famciclovir ganciclovir .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Prednisolone</keyword>
	<keyword>Valacyclovir</keyword>
</DOC>